Multiple Sclerosis News Today13h
Targeting TYK2 in brain seen as potential strategy for MS treatment
A small molecule that blocks TYK2 in the brain showed promise for reducing disease activity in mouse models of multiple ...
Applied Clinical Trials Online16h
API-CAT Trial Shows Reduced-Dose Eliquis Matches Full Dose in Preventing Venous Thromboembolism, Lowers Bleeding Risk in Cancer Patients
The Phase III API-CAT trial found that extended anticoagulant therapy with reduced-dose Eliquis (apixaban) was noninferior to ...
TG Therapeutics rises after trial setback for high dose version of Roche’s MS drug
Roche (OTCQX:RHHBY) (OTCQX:RHHBF) announced Wednesday that a Phase 3 trial for a high-dose version of its multiple sclerosis ...
The American Journal of Managed Care15h
Orca-T Shows Efficacy, Reduced GVHD Risk in Acute Leukemia, MDS: Caspian Oliai, MD
Caspian Oliai, MD, MS, medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center, discusses ...
BMJ11h
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
41 St. Joseph's Health Care London and University of Western Ontario, London, Ontario, Canada Objective The 1980 American College of Rheumatology (ACR) classification criteria for systemic sclerosis ...